medigraphic.com
Colegio de Medicina Interna de México.

2015, Number 2

<< Back Next >>

Med Int Mex 2015; 31 (2)

Conn’s syndrome

Uresti-Flores EL, Saucedo-Treviño LG, Gámez-Barrera H, Melo-Gastón M, Valdés-Cruz E, García-de León LE

Language: Spanish
References: 20
Page: 210-216
PDF size: 625.71 Kb.


ABSTRACT

Aldosteronoma is a suprarrenal cortex tumor producer of aldosterona and it is the main cause of primary hyperaldosteronism, is diagnosed mainly among 30 and 60 years old, predominantly in women 1.5:1, usually unilateral but occasionally bilateral (8%). Most patients with hyperaldosteronism have normal serum potassium levels at diagnosis, which should not be an exclusion criterion for the diagnosis. We must suspect aldosteronoma in patients with hypertension, hypokalemia and metabolic alkalosis. Also we can search in patients with family history of primary hyperaldosteronism, incidentaloma, hypertension and previous study of secondary hypertension. This paper reports the case of a 39-year-old female patient, with hypertension and hipokalemia. The diagnosis has made with high aldosteron serum levels and abdominal computed axial tomography, which showed a right adrenal tumor without renal involvement. The laparoscopic adrenalectomy and pathology study confirmed aldosteronoma. Aldosteronoma has a diverse clinical presentation, this is why we need to establish it as a differential diagnosis in patients with secondary hypertension. Laparoscopic adrenalectomy is the gold standard treatment for the aldosteronoma.


REFERENCES

  1. Takeuchi T, Inoue T, Kanemoto K, et al. Possible origin of aldosteronoma from adrenohepatic fusion resulting in intrahepatic tumor. Open J Urol 2013;3:223-226.

  2. Mackenzie TJ, Lilligard JB. Aldosteronomas-state of the art. Surg Clin N Am 2009;89:1241-1253.

  3. Beinzie V, Auskas JB. Surgical treatment options for aldosteronomas. Wideochir Inne Tech Malo Inwazyjne 2012;7:260-267.

  4. Kim SH, Ahn JH, Hong HC. Changes in the clinical manifestations of primary aldosteronism. KJIM 2014;29:217-225.

  5. Gómez-Hernández K, Chih How Chen K. Hiperaldosteronismo primario: una nueva perspectiva. AMC 2007;49:389- 396.

  6. Funder JW, Carey RM. Case detection, diagnosis and treatment of patients with primary aldosteronism: An Endocrine Society Clinical Practice Guideline. JCEM 2008;3265-3281.

  7. Young WF Jr. The incidentally discovered adrenal mass. NEJM 2006;601-609.

  8. Schmiemann G, Gebhardt K. Hummers-Pradier E. Prevalence of hyperaldosteronism in primary care patients with resistant hypertension. JABFP 2012;1:98-103.

  9. Díaz JC, Contreras Zúñiga E. Síndrome de Conn: descripción de un caso clínico. Hipetens Riesgo Vasc (Madrid) 2007;24:181-184.

  10. Young WF. Primery aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007;66:607-618.

  11. Vilar L, Canadas V. Adrenal incidentalomas diagnostic evaluation and long-term follow-up. Endocr Prac 2008;13:269- 278.

  12. Herrera MF, Correa-Rotter R. Síndrome de Conn: una experiencia quirúrgica. Rev Invest Clin 2003;55:484-488.

  13. Adrogue H. Sodium and potassium in the pathogenesis of hypertension. NEJM 2007;365:1966-1978.

  14. Moser M. Resistant or difficult-to-control hypertension. NEJM 2006;365:533-560.

  15. Amat-Villegas I, Beloqui R. Pt-to-C doble adenoma corticosuprarrenal más presencia de cuerpos de espirinolactona. Rev Esp Patol 2005;38:188-191.

  16. Aranova A, Fahey T. Management of hypertension in primary aldosteronism. Worl J Cardiol 2014;6:227-233.

  17. Amar et al. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis 2010;5:9.

  18. Indra T, Holaj R, Strauch B, Rosa J, et al. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2014 Sep 30. pii; http://www.ncbi.nlm. nih.gov/pubmed/25271250

  19. Rossi GP, Cesari M, Cuspidi C, Maiolino G, Cicala MV, Bisogni V, Mantero F, Pessina AC, et al. Response to effectiveness of adrenalectomy and aldosterone antagonists for long-term treatment of primary aldosteronism. Hypertension 2013;62(4):e14. http://www.ncbi.nlm.nih. gov/pubmed/24156100

  20. Lin YH, Wu XM, Lee HH, Lee JK, et al, TAIPAI Study Group. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism. J Hypertens 2012;30:1606-1613. http://www.ncbi.nlm.nih.gov/pubmed/22688266




2020     |     www.medigraphic.com